Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
In this podcast episode, listen to David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, discuss key data for gynecologic cancers presented at the 2023 SGO Annual Meeting, including practice changing data for endometrial cancers, and for novel combinations in ovarian cancer, and studies exploring sequencing immunotherapy and chemoradiation in cervical cancer.
Decera Clinical Education Oncology Podcast · Brian Slomovitz MD, Cervical Cancer, David Miller MD, Dmitriy Zamarin MD, dMMR, Dostarlimab, Endometrial Cancer, ENGOT-EN6, GOG 3026, GOG-303, Lenvatinib, Letrozole, LGSC, Linda Duska, MD MPH, Manzoor Mirza MD, MSI-H, MSS, NRG GY017, NRG GY018, Ovarian Cancer, Pembrolizumab, pMMR, Ramez N. Eskander
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, provide expert insights on practice-changing data and other new findings presented at SGO 2023 in endometrial, cervical, and ovarian cancers, including:
- NRG GY018: randomized phase III study evaluating standard of care of carboplatin plus paclitaxel with or without pembrolizumab as frontline treatment for patients with endometrial cancer
- ENGOT-EN6/GOG-3031/RUBY: randomized, placebo-controlled phase III study of dostarlimab plus standard-of-care chemotherapy in primary advanced or recurrent endometrial cancer
- Phase I NRG-GY017 study of priming-dose atezolizumab before or concurrently with chemoradiotherapy in locally advanced high-risk cervical cancer
- Randomized phase II study of chemoradiation plus pembrolizumab immunotherapy in locally advanced cervical cancer
- GOG 3026: phase II trial of letrozole plus ribociclib in women with recurrent low-grade serous ovarian cancer
Presenters:
David Scott Miller, MD, FACOG, FACS
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Director and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics & Gynecology
Fred F. Florence Bioinformation Center
University of Texas Southwestern Medical Center
Medical Director of Gynecologic Oncology Chair, Cancer Committee
Parkland Health & Hospital System
Dallas, Texas
Linda Duska, MD, MPH
Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia
Content supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure Inc., and Seagen Inc.
Link to full program: bit.ly/424E3Uq
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.